Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
7 September 2015 |
Main ID: |
NCT02357693 |
Date of registration:
|
31/01/2015 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Neurokinin Receptor Antagonist Associated to Ondansetron in PONV
PONV |
Scientific title:
|
Effect of the Association of Neurokinin-1 Receptor Antagonist Aprepitant to Dexamethasone/Ondansetron in the Incidence of Postoperative Nausea and Vomiting in High Risk Apfel Score Patients |
Date of first enrolment:
|
February 2015 |
Target sample size:
|
90 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02357693 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Prevention
|
Phase:
|
Phase 4
|
|
Countries of recruitment
|
Brazil
| | | | | | | |
Contacts
|
Name:
|
Hazem a Ashmawi, phD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
University of Sao Paulo |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- high risk patients for nausea and vomiting
Exclusion Criteria:
- cardiovascular disease, or hypersensibility to any of the drugs involved in the study
Age minimum:
18 Years
Age maximum:
70 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Postoperative Nausea and Vomiting
|
Intervention(s)
|
Drug: Aprepitant
|
Primary Outcome(s)
|
Incidence of nausea and vomiting in postoperative period
[Time Frame: 24 hours]
|
Secondary ID(s)
|
CEP 280/12
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|